| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Technical Advance |
From the Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, California
Tissue microarray technology is a new method used to analyze several hundred tumor samples on a single slide allowing high throughput analysis of genes and proteins on a large cohort. The original methodology involves coring tissues from paraffin-embedded tissue donor blocks and placing them into a single paraffin block. One difficulty with paraffin-embedded tissue relates to antigenic changes in proteins and mRNA degradation induced by the fixation and embedding process. We have modified this technology by using frozen tissues embedded in OCT compound as donor samples and arraying the specimens into a recipient OCT block. Tumor tissue is not fixed before embedding, and sections from the array are evaluated without fixation or postfixed according to the appropriate methodology used to analyze a specific gene at the DNA, RNA, and/or protein levels. While paraffin tissue arrays can be problematic for immunohistochemistry and for RNA in situ hybridization analyses, this method allows optimal evaluation by each technique and uniform fixation across the array panel. We show OCT arrays work well for DNA, RNA, and protein analyses, and may have significant advantages over the original technology for the assessment of some genes and proteins by improving both qualitative and quantitative results.
This article has been cited by other articles:
 |
|
 |
|
  R. L. Camp, V. Neumeister, and D. L. Rimm A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers J. Clin. Oncol., December 1, 2008; 26(34): 5630 - 5637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Degen, F. Brellier, R. Kain, C. Ruiz, L. Terracciano, G. Orend, and R. Chiquet-Ehrismann Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell Behavior Cancer Res., October 1, 2007; 67(19): 9169 - 9179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Howat, A. Warford, J. N. Mitchell, K. F. Clarke, J. S. Conquer, and J. McCafferty Resin Tissue Microarrays: a Universal Format for Immunohistochemistry J. Histochem. Cytochem., October 1, 2005; 53(10): 1189 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S G Jhavar, C Fisher, A Jackson, S A Reinsberg, N Dennis, A Falconer, D Dearnaley, S E Edwards, S M Edwards, M O Leach, et al. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique J. Clin. Pathol., May 1, 2005; 58(5): 504 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zheng, R. Simon, M. Mirlacher, R. Maurer, T. Gasser, T. Forster, P. A. Diener, M. J. Mihatsch, G. Sauter, and P. Schraml TRIO Amplification and Abundant mRNA Expression Is Associated with Invasive Tumor Growth and Rapid Tumor Cell Proliferation in Urinary Bladder Cancer Am. J. Pathol., July 1, 2004; 165(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Struckmann, P. Schraml, R. Simon, K. Elmenhorst, M. Mirlacher, J. Kononen, and H. Moch Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma Cancer Res., March 1, 2004; 64(5): 1632 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Packeisen, E Korsching, H Herbst, W Boecker, and H Buerger Demystified ... Tissue microarray technology Mol. Pathol., August 1, 2003; 56(4): 198 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ginestier, E. Charafe-Jauffret, F. Bertucci, F. Eisinger, J. Geneix, D. Bechlian, N. Conte, J. Adelaide, Y. Toiron, C. Nguyen, et al. Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers Am. J. Pathol., October 1, 2002; 161(4): 1223 - 1233. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
